· 1 source · Verified

General Medicine Raises $120M Series B to Build a Healthcare Store

Andreessen Horowitz led General Medicine's $120 million Series B as the company expands a nationwide catalog for medications, labs, telehealth and specialist care.

By Venture Capital Tracker

Editorial team

Share
General Medicine Series B $120M

General Medicine has raised $120 million in Series B financing led by Andreessen Horowitz, with participation from Matrix, VXI Capital, Eli Lilly and Company, Mercy Health through Granger Management, and BoxGroup. The round brings total funding to $152 million.

Deal details & investors

Funding event

General Medicine

$120M Series B

Led by Andreessen Horowitz

What General Medicine is building

The company describes itself as a nationwide healthcare store. Its catalog includes more than 2,900 products and services across medications, laboratory tests, telehealth, specialist e-consults and selected in-person visits and procedures.

The product thesis is straightforward: let people search and compare care in a format closer to ecommerce, including upfront prices with and without insurance.

Why the round stands out

A $120 million Series B is large for a healthcare marketplace. The capital reflects the difficulty of building a national healthcare transaction layer: provider networks, pricing, insurance workflows, clinical operations and compliance all have to work together.

The key question is whether General Medicine can become a repeat purchasing layer rather than a collection of one-off healthcare transactions. Evidence to watch includes repeat usage, breadth of covered services, provider economics and whether transparent pricing actually changes how consumers shop for care.

Follow Venture Capital Tracker on Google

Add VCT as a preferred source to see more of our venture-capital reporting in Google Search.

Add as preferred source

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Related articles

See all

Frequently Asked Questions

Direct answers to common questions about this topic

Sources & references

1 source

Reporting and documents referenced in this article.

  1. General Medicine — Series B announcement

Companies and investors in this story

Explore their profiles or save them for later.

View watchlist
Back to Blog